相似文献
1
Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders.
Genome Med. 2010 Mar 30;2(3):22. doi: 10.1186/gm143.
2
Proteomics and metabolomics of HIV-associated neurocognitive disorders: A systematic review.
J Neurochem. 2021 May;157(3):429-449. doi: 10.1111/jnc.15295. Epub 2021 Jan 22.
3
Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases.
J Alzheimers Dis. 2005 Mar;8(4):377-86. doi: 10.3233/jad-2005-8407.
4
Novel biomarkers for lysosomal storage disorders: Metabolomic and proteomic approaches.
Clin Chim Acta. 2020 Oct;509:195-209. doi: 10.1016/j.cca.2020.06.028. Epub 2020 Jun 17.
5
Biomarker discovery in neurodegenerative diseases: a proteomic approach.
Neurobiol Dis. 2009 Aug;35(2):157-64. doi: 10.1016/j.nbd.2008.09.004. Epub 2008 Sep 26.
6
Proteomic approaches in lung cancer biomarker development.
Expert Rev Proteomics. 2009 Feb;6(1):27-42. doi: 10.1586/14789450.6.1.27.
7
Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.
Electrophoresis. 2011 Apr;32(9):967-75. doi: 10.1002/elps.201000588. Epub 2011 Mar 30.
8
Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes.
J Proteome Res. 2011 Oct 7;10(10):4769-88. doi: 10.1021/pr2005555. Epub 2011 Aug 29.
10
[Toward acceleration of drug development with proteomic and metabolomic biomarkers].
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku. 2013(131):20-4.
引用本文的文献
1
A Pilot Investigation of the Association Between Vpr Amino Acid Substitutions and Peripheral Immune Marker Levels in People With Human Immunodeficiency Virus: Implications for Neurocognitive Impairment.
Open Forum Infect Dis. 2024 Feb 27;11(3):ofae111. doi: 10.1093/ofid/ofae111. eCollection 2024 Mar.
2
Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients.
AIDS. 2017 Jun 19;31(10):1365-1378. doi: 10.1097/QAD.0000000000001503.
3
Nano-ART and NeuroAIDS.
Drug Deliv Transl Res. 2016 Oct;6(5):452-72. doi: 10.1007/s13346-016-0293-z.
4
Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders.
J Neurovirol. 2016 Jun;22(3):366-75. doi: 10.1007/s13365-015-0406-3. Epub 2015 Dec 21.
5
Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric Symptoms.
Front Psychiatry. 2015 Jul 14;6:97. doi: 10.3389/fpsyt.2015.00097. eCollection 2015.
6
Ibudilast reverses the decrease in the synaptic signaling protein phosphatidylethanolamine-binding protein 1 (PEBP1) produced by chronic methamphetamine intake in rats.
Drug Alcohol Depend. 2015 Jul 1;152:15-23. doi: 10.1016/j.drugalcdep.2015.04.012. Epub 2015 Apr 30.
7
Plasma proteomic analysis of simian immunodeficiency virus infection of rhesus macaques.
J Proteome Res. 2010 Sep 3;9(9):4721-31. doi: 10.1021/pr1004345.
本文引用的文献
1
Sera proteomic biomarker profiling in HIV-1 infected subjects with cognitive impairment.
Proteomics Clin Appl. 2008 Oct;2(10-11):1498-507. doi: 10.1002/prca.200780114. Epub 2008 Sep 10.
2
Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy.
J Neurovirol. 2009 Sep;15(5-6):360-70. doi: 10.3109/13550280903131915.
3
HIV-1 neuroimmunity in the era of antiretroviral therapy.
Neurobiol Dis. 2010 Mar;37(3):542-8. doi: 10.1016/j.nbd.2009.12.015. Epub 2010 Jan 4.
4
Quantitative plasma proteomic profiling identifies the vitamin E binding protein afamin as a potential pathogenic factor in SIV induced CNS disease.
J Proteome Res. 2010 Jan;9(1):352-8. doi: 10.1021/pr900685u.
5
A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection.
Neuron. 2009 Oct 15;64(1):133-45. doi: 10.1016/j.neuron.2009.09.042.
6
Morbidity and mortality in HIV-infected individuals - a shift towards comorbidities.
Swiss Med Wkly. 2009 Oct 3;139(39-40):564-70. doi: 10.4414/smw.2009.12662.
7
CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.
J Neuroimmune Pharmacol. 2009 Dec;4(4):430-47. doi: 10.1007/s11481-009-9174-2. Epub 2009 Sep 19.
8
Social and structural determinants of HAART access and adherence among injection drug users.
Int J Drug Policy. 2010 Jan;21(1):4-9. doi: 10.1016/j.drugpo.2009.08.003. Epub 2009 Sep 10.
9
Synaptic proteins linked to HIV-1 infection and immunoproteasome induction: proteomic analysis of human synaptosomes.
J Neuroimmune Pharmacol. 2010 Mar;5(1):92-102. doi: 10.1007/s11481-009-9168-0. Epub 2009 Aug 20.
10
Cognitive neuropsychology of HIV-associated neurocognitive disorders.
Neuropsychol Rev. 2009 Jun;19(2):152-68. doi: 10.1007/s11065-009-9102-5. Epub 2009 May 22.
Zotero 插件